BridgeMD
Combining short and long-acting local anaesthetics in ultrasound-guided infraclavicular brachial plexus nerve block.
EU CTIS ID: 2023-510028-63-00
What this study is testing
To investigate the lateral infraclavicular plexus brachialis (LIC) block as only anesthesia for hand surgery. We will compare the duration and on-set time of the LIC block with short- and long-acting local anesthetics in combination with different concentrations but at the same volume. Both motor and sensory blockade properties will also be assessed.
- Phase III and phase IV (Integrated)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients undergoing hand surgery for antebrachial fractures or arthroplasty/alloplasty of a thumb base joint in the hand
You likely can't join if
- BMI > 40 kg/m2
- Weight < 60 kg
- Age < 18 years
- ASA physical status classification system grade >3
- Allergy to experimental drugs
- Patients who cannot cooperate with the examinations or treatment
See the full eligibility criteria
- Patients undergoing hand surgery for antebrachial fractures or arthroplasty/alloplasty of a thumb base joint in the hand
- BMI > 40 kg/m2
- Weight < 60 kg
- Age < 18 years
- ASA physical status classification system grade >3
- Allergy to experimental drugs
- Patients who cannot cooperate with the examinations or treatment
- Patients who do not understand or speak Danish
- Patients with peripheral or central neurological disease or nerve damage with neurological effect on the upper extremity, where surgery is required
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.